Investigating the antiviral role of cell death-inducing DFF45-like effector B in HCV replication

FEBS Journal

Volumn 281, Issue 16, 2014, Pages 3751-3765

  Singaravelu, Ragunath ^a,b   Delcorde, Julie ^a,b   Lyn, Rodney K ^a   Steenbergen, Rineke H ^c,d   Jones, Daniel M ^e   Tyrrell, David Lorne ^c,d   Russell, Rodney S ^e   Pezacki, John P ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

apoptosis; CARS microscopy; cell inducing DFF45 like effector; hepatitis C virus; lipid droplet

Indexed keywords

CASPASE; CELL DEATH INDUCING DFF45 LIKE EFFECTOR B; HOST FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN CELL; LIPID METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REPLICON; UPREGULATION; VIRUS INHIBITION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

APOPTOSIS; CARS MICROSCOPY; CELL-INDUCING DFF45 LIKE EFFECTOR; HEPATITIS C VIRUS; LIPID DROPLET;

APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASE 7; CASPASES; CELL LINE, TUMOR; HEPACIVIRUS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPID METABOLISM; TRIGLYCERIDES; VIRUS REPLICATION;

EID: 84906791184     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12901     Document Type: Article

References (62)

1. Moradpour D, Penin F, &, Rice CM, (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
2. Lindenbach BD, &, Rice CM, (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436, 933-938.
3. Lavanchy D, (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17, 107-115.
4. El-Serag HB, (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264-1273 e1.
5. Crespo G, Marino Z, Navasa M, &, Forns X, (2012) Viral hepatitis in liver transplantation. Gastroenterology 142, 1373-1383 e1.
6. Hoofnagle JH, (2002) Course and outcome of hepatitis C. Hepatology 36, s21-s29.
7. Di Bisceglie AM, McHutchison J, &, Rice CM, (2002) New therapeutic strategies for hepatitis C. Hepatology 35, 224-231.
8. Sarrazin C, Hézode C, Zeuzem S, &, Pawlotsky JM, (2012) Antiviral strategies in hepatitis C virus infection. J Hepatol 56 (Suppl 1), S88-S100.
9. Assis DN, &, Lim JK, (2012) New pharmacotherapy for hepatitis C. Clin Pharmacol Ther 92, 294-305.
10. Fischer R, Baumert T, &, Blum HE, (2007) Hepatitis C virus infection and apoptosis. World J Gastroenterol 13, 4865-4872.
11. Herker E, &, Ott M, (2011) Unique ties between hepatitis C virus replication and intracellular lipids. Trends Endocrinol Metab 22, 241-248.
12. Lyn RK, Kennedy DC, Stolow A, Ridsdale A, &, Pezacki JP, (2010) Dynamics of lipid droplets induced by the hepatitis C virus core protein. Biochem Biophys Res Commun 399, 518-524.
13. Huang H, Sun F, Owen DM, Li WP, Chen Y, Gale M, &, Ye J, (2007) Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 104, 5848-5853.
14. Bassendine MF, Sheridan DA, Felmlee DJ, Bridge SH, Toms GL, &, Neely RDG, (2011) HCV and the hepatic lipid pathway as a potential treatment target. J Hepatol 55, 1428-1440.
15. Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, et al,. (2002) Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99, 15669-15674.
16. Lyn RK, Kennedy DC, Sagan SM, Blais DR, Rouleau Y, Pegoraro AF, Xie XS, Stolow A, &, Pezacki JP, (2009) Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism. Virology 394, 130-142.
17. Pezacki JP, Sagan SM, Tonary AM, Rouleau Y, Belanger S, Supekova L, &, Su AI, (2009) Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus. BMC Chem Biol 9, 2.
18. Inohara N, Koseki T, Chen S, Wu X, &, Nunez G, (1998) CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J 17, 2526-2533.
19. Chen Z, Guo K, Toh SY, Zhou Z, &, Li P, (2000) Mitochondria localization and dimerization are required for CIDE-B to induce apoptosis. J Biol Chem 275, 22619-22622.
20. Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, &, Guguen-Guillouzo C, (2003) The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 278, 18256-18264.
21. Jambunathan S, Yin J, Khan W, Tamori Y, &, Puri V, (2011) FSP27 promotes lipid droplet clustering and then fusion to regulate triglyceride accumulation. PLoS One 6, e28614.
22. Gong J, Sun Z, &, Li P, (2009) CIDE proteins and metabolic disorders. Curr Opin Lipidol 20, 121-126.
23. Xu L, Zhou L, &, Li P, (2012) CIDE proteins and lipid metabolism. Arterioscler Thromb Vasc Biol 32, 1094-1098.
24. Puri V, Konda S, Ranjit S, Aouadi M, Chawla A, Chouinard M, Chakladar A, &, Czech MP, (2007) Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage. J Biol Chem 282, 34213-34218.
25. Zhou Z, Toh SY, Chen Z, Guo K, Ng CP, Ponniah S, Lin SC, Hong W, &, Li P, (2003) Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet 35, 49-56.
26. Ye J, Li JZ, Liu Y, Li X, Yang T, Ma X, Li Q, Yao Z, &, Li P, (2009) Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab 9, 177-190.
27. Zhou L, Xu L, Ye J, Li D, Wang W, Li X, Wu L, Wang H, Guan F, &, Li P, (2012) Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatology 56, 95-107.
28. Li JZ, Lei Y, Wang Y, Zhang YX, Ye J, Xia XY, Pan XM, &, Li P, (2010) Control of cholesterol biosynthesis, uptake and storage in hepatocytes by Cideb. Biochim Biophys Acta 1801, 577-586.
29. Li JZ, Ye J, Xue B, Qi J, Zhang J, Zhou Z, Li Q, Wen Z, &, Li P, (2007) Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes 56, 2523-2532.
30. Chen Z, Norris JY, &, Finck BN, (2010) Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB). J Biol Chem 285, 25996-26004.
31. Steenbergen RHG, Joyce MA, Thomas BS, Jones D, Law J, Russell R, Houghton M, &, Tyrrell DL, (2013) Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers. Hepatology 58, 1907-1917.
32. Singaravelu R, Lyn RK, Srinivasan P, Delcorde J, Steenbergen RH, Tyrrell DL, &, Pezacki JP, (2013) Human serum activates CIDEB-mediated lipid droplet enlargement in hepatoma cells. Biochem Biophys Res Commun 441, 447-452.
33. Blais DR, Lyn RK, Joyce MA, Rouleau Y, Steenbergen R, Barsby N, Zhu LF, Pegoraro AF, Stolow A, Tyrrell DL, et al,. (2010) Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication. J Biol Chem 285, 25602-25612.
34. Yu M, Wang H, Zhao J, Yuan Y, Wang C, Li J, Zhang L, Li Q, &, Ye J, (2013) Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance. Mol Cell Biochem 378, 145-151.
35. Li H, Song Y, Zhang LJ, Li FF, Gu Y, Zhang J, Dong WP, Xue L, Zhang LY, Liu F, et al,. (2012) Cell death-inducing DFF45-like effector b (Cideb) is present in pancreatic beta-cells and involved in palmitate induced beta-cell apoptosis. Diabetes Metab Res Rev 28, 145-155.
36. Christianson JL, Boutet E, Puri V, Chawla A, &, Czech MP, (2010) Identification of the lipid droplet targeting domain of the Cidea protein. J Lipid Res 51, 3455-3462.
37. Gong JY, Sun ZQ, Wu LZ, Xu WY, Schieber N, Xu DJ, Shui GH, Yang HY, Parton RG, &, Li P, (2011) Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. J Cell Biol 195, 953-963.
38. Pezacki JP, Blake JA, Danielson DC, Kennedy DC, Lyn RK, &, Singaravelu R, (2011) Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy. Nat Chem Biol 7, 137-145.
39. Nan X, Tonary AM, Stolow A, Xie XS, &, Pezacki JP, (2006) Intracellular imaging of HCV RNA and cellular lipids by using simultaneous two-photon fluorescence and coherent anti-Stokes Raman scattering microscopies. ChemBioChem 7, 1895-1897.
40. Kennedy DC, Lyn RK, &, Pezacki JP, (2009) Cellular lipid metabolism is influenced by the coordination environment of copper. J Am Chem Soc 131, 2444-2445.
41. Kennedy DC, McKay CS, Legault MC, Danielson DC, Blake JA, Pegoraro AF, Stolow A, Mester Z, &, Pezacki JP, (2011) Cellular consequences of copper complexes used to catalyze bioorthogonal click reactions. J Am Chem Soc 133, 17993-18001.
42. Liu K, Zhou S, Kim JY, Tillison K, Majors D, Rearick D, Lee JH, Fernandez-Boyanapalli RF, Barricklow K, Houston MS, et al,. (2009) Functional analysis of FSP27 protein regions for lipid droplet localization, caspase-dependent apoptosis, and dimerization with CIDEA. Am J Physiol Endocrinol Metab 297, E1395-E1413.
43. Keller P, Petrie JT, De Rose P, Gerin I, Wright WS, Chiang SH, Nielsen AR, Fischer CP, Pedersen BK, &, MacDougald OA, (2008) Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem 283, 14355-14365.
44. Tang X, Xing Z, Tang H, Liang L, &, Zhao M, (2011) Human cell-death-inducing DFF45-like effector C induces apoptosis via caspase-8. Acta Biochim Biophys Sin (Shanghai) 43, 779-786.
45. Tait SW, &, Green DR, (2008) Caspase-independent cell death: leaving the set without the final cut. Oncogene 27, 6452-6461.
46. Alvisi G, Madan V, &, Bartenschlager R, (2011) Hepatitis C virus and host cell lipids: an intimate connection. RNA Biol 8, 258-269.
47. Paul D, Hoppe S, Saher G, Krijnse-Locker J, &, Bartenschlager R, (2013) Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment. J Virol 87, 10612-10627.
48. Lyn RK, Singaravelu R, Kargman S, O'Hara S, Chan H, Oballa R, Huang Z, Jones DM, Ridsdale A, Russell RS, et al,. (2014) Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci Rep 4, 4549. doi: 10.1038/srep04549.
49. Kountouras J, Zavos C, &, Chatzopoulos D, (2003) Apoptosis in hepatitis C. J Viral Hepat 10, 335-342.
50. Bantel H, &, Schulze-Osthoff K, (2003) Apoptosis in hepatitis C virus infection. Cell Death Differ 10 (Suppl 1), S48-S58.
51. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge C, Haase J, Janes J, Huss J, et al,. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10, R130.
52. Teodoridis JM, Strathdee G, &, Brown R, (2004) Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker. Drug Resist Updat 7, 267-278.
53. Shlomai A, Rechtman MM, Burdelova EO, Zilberberg A, Hoffman S, Solar I, Fishman S, Halpern Z, &, Sklan EH, (2012) The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance. J Hepatol 57, 867-873.
54. Lugovskoy AA, Zhou P, Chou JJ, McCarty JS, Li P, &, Wagner G, (1999) Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell 99, 747-755.
55. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, &, Liu C, (2007) Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 133, 1649-1659.
56. Stapleford KA, &, Lindenbach BD, (2011) Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J Virol 85, 1706-1717.
57. Blight KJ, Kolykhalov AA, &, Rice CM, (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972-1974.
58. Lohmann V, Körner F, Koch JO, Herian U, Theilmann L, &, Bartenschlager R, (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
59. Koukiekolo R, Jakubek ZJ, Cheng J, Sagan SM, &, Pezacki JP, (2009) Studies of a viral suppressor of RNA silencing p19-CFP fusion protein: a FRET-based probe for sensing double-stranded fluorophore tagged small RNAs. Biophys Chem 143, 166-169.
60. Pegoraro AF, Ridsdale A, Moffatt DJ, Jia Y, Pezacki JP, &, Stolow A, (2009) Optimally chirped multimodal CARS microscopy based on a single Ti:sapphire oscillator. Opt Express 17, 2984-2996.
61. Dyer BW, Ferrer FA, Klinedinst DK, &, Rodriguez R, (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 282, 158-161.
62. T) method. Methods 25, 402-408.